SCIC officials visit Traphaco’s major pharmaceutical plant
As a major shareholder that holds up to 35.67% of the charter capital in Traphaco JSC, the State Capital Investment Corporation (SCIC) officials visited and met with Traphaco’s leaders on July 20th.
Attending the meeting between SCIC and Traphaco JSC were Mr. Nguyen Duc Chi, SCIC Chairman, Mr. Nguyen Chi Thanh, SCIC Deputy General Director, officials of SCIC’s Investment Management Department No. 3, the SCIC’s official in charge of SCIC’s investment in Traphaco, Mr. Tran Tuc Ma, Traphaco Chief Executive Officer (CEO), Mrs. Hoang Thi Ruoc, Traphaco Vice CEO and other Traphaco officials.
On behalf of the Board of Directors of Traphaco, CEO Tran Tuc Ma presented a report on the business and production activities of Traphaco in the first six months of 2016 and talked about corporate governance.
Accordingly, in the first 6 months 2016, Traphaco’s consolidated revenue reached VND1,030 billion, up 15% over the same period of 2015. Also, the company’s consolidated profit was estimated at VND100 billion, an increase of 15% year on year. Traphaco is urgently completing the construction of the Vietnam Pharmaceutical Plant, which is scheduled to run on trial in January 2017.
After the meeting, SCIC and Traphaco leaders paid a visit to the Traphaco High-Tech JSC to check the construction pace of the Vietnam Pharmaceutical Plant.
During the visit, the delegation was provided with brief introduction about the Vietnam Pharmaceutical Plant project.
Specifically, this plant applies the most modern technology, which meets the GMP – EU standards. It is also equipped with the most modern waste treatment technology in the world at present. Traphaco has strictly controlled the construction of this plant from the beginning to ensure that all standards would be satisfied. Traphaco is determined to put the plant into operation in early 2017 as its initial plan.
SCIC Chairman Nguyen Duc Chi highly appreciated the design and construction of the Vietnam Pharmaceutical Plant. He believed that the project will help create jobs for many local people and this is a large-scale project of Traphaco.
The SCIC Chairman also asked Traphaco to pay more attention to the issue of environmental protection. He emphasized that production must go with effective environmental protection.
The Vietnam Pharmaceutical Plant is built with a total investment capital of VND477 billion, of which VND300 billion for infrastructure and VND120 billion for the production lines. The project consists of more than 20 different bid packages and will be completed in late 2016.
SCIC Chairman Nguyen Duc Chi also congratulated Traphaco for its good production and business results in the first 6 months of this year. He highly appreciated the efforts of the leaders and all employees of the company in recent years.
The SCIC top official also pledged that SCIC, as a major shareholder of Traphaco, will continue create favorable conditions for the development of Traphaco. This is the firm basis for Traphaco’s further development in the coming time.